Predict your next investment

Corporation
HEALTHCARE | Pharmaceuticals / Drugs
galenabiopharma.com

See what CB Insights has to offer

Stage

Acq - P2P | Acquired

About Galena Biopharma

Galena Biopharma (Nasdaq: GALE) is a biopharmaceutical company developing and commercializing innovative, targeted oncology therapeutics that address major medical needs across the full spectrum of cancer care.

Galena Biopharma Headquarter Location

2000 Crow Canyon Place Suite 380

San Ramon, California, 94583,

United States

855-855-4253

Latest Galena Biopharma News

Worldwide Keloid Treatment Industry to 2026 - Featuring Renovo Group, Galena Biopharma and Novartis Among Others - ResearchAndMarkets.com

Jun 17, 2021

June 17, 2021 07:43 AM Eastern Daylight Time Keloid scars are heap-up scars which are developed with injuries caused due to acne, burns, ear piercing, chickenpox, surgical cuts, scratches and vaccination sites and build up abruptly on the skin surface. Keloid scars develop commonly in people between age group 10 to 20 years of age. Globally, development of advance technology based treatment, rise in the appearance consciousness, and increasing awareness about scare treatment products, and expenditure on personal care, and changing lifestyle are the prime growth drivers of global keloid treatment market. In addition, increase in adoption of radiation therapy, surgical intervention, and steroid injections and, emerging economies such as China, India and others, will create new opportunities for global keloid treatment market. However, higher cost of treatment, and risk of side effects and complications during treatment are the key restraints for global keloid treatment market. This report identifies the global keloid treatment market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to global keloid treatment market. Geographically North America dominated global keloid treatment market, and Asia Pacific is projected to have fastest growth, owing to rapidly increasing aging population, growing disposable income, rising focus on personal well-being and modernizing healthcare infrastructure in this region. Among all the treatments, surgical treatment segment has the highest market share in global keloid treatment market. Companies Mentioned

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Galena Biopharma

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Galena Biopharma is included in 3 Expert Collections, including Pharma Startups.

P

Pharma Startups

11,639 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

C

Cancer Therapeutics

1,179 items

Pharmaceutical and biotechnology companies with cancer therapy drug candidates.

C

Cancer

3,604 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

Galena Biopharma Patents

Galena Biopharma has filed 2 patents.

The 3 most popular patent topics include:

  • Antigonadotropins
  • Clusters of differentiation
  • Gynaecological cancer
patents chart

Application Date

Grant Date

Title

Related Topics

Status

5/31/2016

6/12/2018

Monoclonal antibodies, Clusters of differentiation, Transcription factors, Immunology, Immune system

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

5/31/2016

00/00/0000

Grant Date

6/12/2018

00/00/0000

Title

Subscribe to see more

Related Topics

Monoclonal antibodies, Clusters of differentiation, Transcription factors, Immunology, Immune system

Subscribe to see more

Status

Grant

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.